2021
DOI: 10.51253/pafmj.v71i6.6977
|View full text |Cite
|
Sign up to set email alerts
|

Role of Interleukin-6 and Procalcitonin as Inflammatory Biomarkers in Evaluating Covid-19 Disease Severity on HRCT Chestan Experience at CMH Quetta

Abstract: Objective: To explore the relation of Interleukin-6 and Procalcitonin with COVID-19 severity on high resolution computerized tomogram (HRCT) chest. Study Design: Randomized Control Trial (NCT04945811). Place and Duration of study: Pathology Department, Combined Military Hospital Quetta, from April 2020 to May 2021. Methodology: Serum Interleukin-6 and Procalcitonin of 100 consenting COVID-19 positive patients from April 2020 to May 2021 were assessed at Pathology department Combined Military … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 18 publications
0
0
0
Order By: Relevance